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Leukemia-associated Rho guanine-nucleotide exchange factor (LARG) belongs to the subfamily of Dbl
homology RhoGEF proteins (including p115 RhoGEF and PDZ-RhoGEF) that possess amino-terminal regu-
lator of G protein signaling (RGS) boxes also found within GTPase-accelerating proteins (GAPs) for hetero-
trimeric G protein  subunits. p115 RhoGEF stimulates the intrinsic GTP hydrolysis activity of G12/13
subunits and acts as an effector for G13-coupled receptors by linking receptor activation to RhoA activation.
The presence of RGS box and Dbl homology domains within LARG suggests this protein may also function as
a GAP toward specific G subunits and couple G activation to RhoA-mediating signaling pathways. Unlike
the RGS box of p115 RhoGEF, the RGS box of LARG interacts not only with G12 and G13 but also with
Gq. In cellular coimmunoprecipitation studies, the LARG RGS box formed stable complexes with the
transition state mimetic forms of Gq, G12, and G13. Expression of the LARG RGS box diminished the
transforming activity of oncogenic G protein-coupled receptors (Mas, G2A, and m1-muscarinic cholinergic)
coupled to Gq and G13. Activated Gq, as well as G12 and G13, cooperated with LARG and caused
synergistic activation of RhoA, suggesting that all three G subunits stimulate LARG-mediated activation of
RhoA. Our findings suggest that the RhoA exchange factor LARG, unlike the related p115 RhoGEF and
PDZ-RhoGEF proteins, can serve as an effector for Gq-coupled receptors, mediating their functional linkage
to RhoA-dependent signaling pathways.
Four classes of heterotrimeric G alpha proteins, Gs, Gi, Gq,
and G12, couple heptahelical G protein-coupled receptors
(GPCRs) to effectors to relay extracellular signals into eukary-
otic cells (14). Each of these heterotrimeric G proteins is
composed of an , , and  subunit. The GDP-bound hetero-
trimer is an inactive form of the G protein. Ligand-bound,
activated receptors catalyze the exchange of GDP by GTP on
the G subunit, leading to heterotrimer dissociation and acti-
vation of signaling pathways by the separated G protein sub-
units (G and G).
An important mechanism used to control the duration and
sensitivity of G protein-mediated signaling is alteration of the
intrinsic GTPase activity of G subunits. Regulator of G pro-
tein signaling (RGS) proteins are a newly described superfam-
ily of G protein signaling modulators that each contains a
conserved domain (the RGS box) that interacts specifically
with activated G subunits. Biochemical studies have demon-
strated that the RGS box functions primarily as a GTPase-
accelerating protein (GAP) for G subunits, accelerating their
intrinsic GTPase activities (32, 36). Most of the characterized
RGS proteins inhibit signaling pathways that use Gi and Gq
heterotrimers as signal transducers. However, p115 RhoGEF/
Lsc, a guanine nucleotide exchange factor (GEF) for the small
GTPase RhoA (11, 16), has recently been shown to have an
RGS box with GAP activity for G12 and G13 (24) that can
block the signaling and/or transforming activity of GPCRs cou-
pled to G12/13 (28, 35, 45).
Similar to the G subunits, the Rho family of small GTPases
are guanine nucleotide binding proteins that function as mo-
lecular switches that cycle between active GTP- and inactive
GDP-bound states (3, 40). The best-characterized members of
this family are RhoA, Rac1, and Cdc42. Rho family proteins
mediate a wide range of cellular activities that include actin
cytoskeletal reorganization as well as cell growth and transfor-
mation (13, 47). Two major classes of regulatory proteins mod-
ulate cellular control of the GDP/GTP cycle of this family of
proteins. Dbl family proteins act as GEFs to promote forma-
tion of the active GTP-bound protein, whereas Rho GTPase-
activating proteins stimulate the intrinsic GTPase activity to
convert these small GTPases to their inactive GDP-bound
states (22).
A large body of research suggests that certain cellular phe-
notypes elicited by GPCRs are dependent upon the activation
of Rho GTPase-controlled signaling pathways. For example,
various ligands that stimulate GPCRs cause activation of Rho
GTPase-dependent changes in actin organization (3, 40).
Moreover, various GPCRs transform NIH 3T3 cells by activa-
tion of specific Rho family members, including Mas (coupled
to Gq and Gi), G2A (coupled to G13 and Gi), PAR-1
(coupled to Gi, Gq, and the G12 family) and KSHV-GPCR
(primarily to G13, also Gq and Gi) (20, 28, 35, 45; I. E.
Zohn, M. Symons, C. J. Der, and J. Boyer, unpublished data).
In addition, Gq, G12, and G13 induce the formation of
stress fibers, activation of the serum response factor (SRF),
and apoptosis in fibroblast cells through the small GTPase
RhoA (1, 4, 30, 45).
The mechanism by which GPCRs cause activation of RhoA
has been determined for G13-coupled receptors. Hart et al.
and Kozasa et al. reported that activated G13 binds to and
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stimulates the GEF activity of p115 RhoGEF in vitro, a Dbl
homology (DH) domain-containing protein that also possesses
an amino-terminal RGS box capable of GAP activity towards
both G12 and G13. Thus, p115 RhoGEF serves as an ef-
fector molecule for GTP-bound G13, which activates the
GEF function of the DH domain by a G13-RGS box inter-
action. Importantly, G12 did not stimulate the GEF activity
of p115 RhoGEF in vitro (15, 24).
Subsequent to these studies, Fukuhara et al. and Jackson
et al. reported that PDZ-RhoGEF/KIAA0380/GTRAP48,
another RGS box-containing Dbl family protein and RhoA-
specific GEF, also interacts with G12 and G13 (10, 19).
Furthermore, coexpression of G12 and G13 enhanced
PDZ-RhoGEF-mediated SRF activation. However, Wells et
al. recently determined that the rat ortholog of PDZ-RhoGEF,
GTRAP48, while capable of binding G13, neither exhibits
significant GAP activity toward G12/13 nor is stimulated by
G13 to increase its guanine nucleotide exchange activity in
vitro (41). Thus, there is currently no clear evidence that PDZ-
RhoGEF/GTRAP48 serves as an effector of G subunits and
the Dbl family protein(s) that promotes RhoA activation by
G subunits i, q, and 12 has not been identified.
Leukemia-associated Rho GEF (LARG) (KIAA0382) is
a Dbl family member similar to PDZ-RhoGEF and p115
RhoGEF that was identified recently as a fusion partner with
mixed-lineage leukemia protein in a patient with acute myeloid
leukemia (23). Like all Dbl family proteins, LARG possesses a
DH domain followed by a carboxy-terminal pleckstrin homol-
ogy (PH) domain (5, 43). It has previously been shown that the
LARG DH domain serves as a GEF for RhoA but not for
Rac1 or Cdc42 (31). In addition to the tandem DH-PH do-
main, LARG also contains a PDZ domain likely to promote
protein-protein interactions (37) and an RGS box that may
function as a GTPase-activating protein for G subunits. In
this study, we determined that the LARG RGS box is a nega-
tive regulator of Gq, G12, and G13 in vivo and, when co-
expressed with activated G12, G13, or Gq, it synergistically
enhanced LARG formation of GTP-bound RhoA and stimu-
lation of SRF activity. These observations suggest that LARG
may be an effector of Gq in cells, linking Gq-coupled as well
as G12- and G13-coupled GPCRs to RhoA activation.
MATERIALS AND METHODS
Molecular constructs. The full-length, N308, and N754 LARG expression
constructs have been described previously (31). Full-length LARG and p115
RhoGEF cDNA (the latter was a kind gift from Gideon Bollag, Onyx) (16) were
used as templates for PCR to generate cDNA sequences encoding the isolated
RGS boxes (residues 1120 to 1491 and 1 to 246, respectively) with flanking
BamHI sites for subcloning into pCGN-hygro, a eukaryotic expression vector
which provides an in-frame, amino-terminal hemagglutinin (HA) epitope tag.
The cDNA sequence encoding full-length muscarinic acetylcholine receptor 1
(m1-mAChR; a kind gift of Ernest Peralta, Harvard) was modified by PCR to
include 5 BamHI and 3 EcoRI restriction sites for subcloning into the BamHI
and EcoRI sites of pBabe-puro eukaryotic expression vector (29).
The following pcDNA3 eukaryotic expression plasmids containing cDNA se-
quences encoding wild-type (wt) or GTPase-deficient constitutively activated G
subunits were kindly provided by Henry Bourne (University of California at San
Francisco): Gq (wt), Gq (Q229L), G13 (wt), G13 (Q226L), G12 (wt), and
G12 (Q229L). All cDNA sequences were sequenced to verify the identity and
accuracy of the coding sequence.
Cell culture and transformation assay. NIH 3T3 mouse fibroblasts were cul-
tured in Dulbecco’s modified Eagle’s medium supplemented with 10% calf
serum (designated growth medium). DNA transfections for primary focus for-
mation transformation assays were performed with calcium phosphate precipi-
tation as described previously (6). For secondary focus formation transformation
assays, NIH 3T3 cells stably expressing m1-mAChR alone or together with either
the LARG- or the p115-RGS box were established by cotransfection of pBabe-
m1-mAChR (puromycin resistant) with pCGN-LARG-RGS or pCGN-p115-
RGS constructs (hygromycin resistant) and isolation of drug-resistant colonies
after growth in medium supplemented with hygromycin (400 g/l) and puro-
mycin (1 mg/ml). Multiple drug-resistant colonies (100) were pooled together
to establish the stable cell lines. For each transformation assay, parallel cell lines
were established that contained the cognate empty vector and used as controls.
Transfected cultures were maintained in growth medium for 14 days, fixed, and
stained with crystal violet (0.5%), and the number of foci of transformed cells
was quantitated.
Coimmunoprecipitations. NIH 3T3 cells were cotransfected with plasmids
expressing HA epitope-tagged LARG- or p115-RGS box together with wt G12,
G13, and Gq by using the Lipofectamine Plus reagent as described by the
manufacturer (Life Technologies). After culture for 48 h, cells were lysed for 20
min on ice in 0.7 ml of buffer A (20 mM Tris [pH 7.5], 1 mM dithiothreitol, 100
mM NaCl, 2.5 mM MgCl2, 1 mM EGTA, 1% Triton X-100, 1 mM NaVO4, 10 g
of aprotinin/ml, and 10 g of leupeptin/ml) or buffer A containing 20 mM NaF
and 20 M AlCl3 to activate the alpha subunits (i.e., in the presence of AlF4	).
Lysates were clarified by centrifugation at 16,000 
 g for 30 min and precleared
for 30 min at 4°C with 30 l of a 50% slurry of protein A-agarose beads.
HA-LARG or HA-p115-RGS boxes were immunoprecipitated with anti-HA
mouse monoclonal antibody (12CA5; Roche Biochemicals). Immunoprecipitates
were captured on protein A-agarose beads (Life Technologies, Inc.), washed
three times in their respective lysis buffers, resolved on a 4 to 20% gradient gel,
and analyzed for coimmunoprecipitating proteins by immunoblotting with anti-
Gq (a gift from T. Kendall Harden, University of North Carolina at Chapel
Hill), -G12, or -G13 rabbit polyclonal antiserum (Calbiochem).
Measurement of Rho protein activation in vivo. The activation of Rho proteins
in vivo was determined by using a modification of the assay originally described
by Taylor and Shalloway (38). A glutathione S-transferase (GST) fusion protein
containing the RhoA effector binding domain (RBD) of rhotekin (amino acids 7
to 89) (rhotekin RBD) (25) (provided by Keith Burridge, University of North
Carolina at Chapel Hill) was expressed and purified by a procedure described
previously (25). Seventy percent confluent cultures (100-mm-diameter dishes) of
NIH 3T3 cells were transfected with LARG and G expression plasmids by using
Lipofectamine Plus according to the manufacturer’s protocol. Three hours after
transfection, cells were placed in complete growth medium for 24 h and then
placed in starvation medium containing 0.5% fetal bovine serum for a subse-
quent 24 h. After starvation, cells were rinsed once with 20 mM HEPES (pH 7.4)
and 150 mM NaCl and then lysed in buffer A (50 mM Tris [pH 7], 500 mM NaCl,
0.5 mM MgCl2, 0.01% sodium dodecyl sulfate [SDS], 0.5% deoxycholate, 1%
Triton X-100, 10 g of aprotinin/ml, and 10 g of leupeptin/ml) on ice for 10
min. Lysates were clarified by centrifugation at 16,000 
 g for 4 min. Thirty
micrograms of GST-rhotekin RBD fusion protein immobilized on glutathione-
Sepharose 4B beads (Amersham Pharmacia) was incubated with 1 mg of cell
lysate in a final volume of 0.5 ml for 30 min at 4°C. The beads were washed three
times with lysis buffer A and three times with buffer B (50 mM Tris [pH 7.4], 150
mM NaCl, 1% Triton X-100, 0.5 mM MgCl2, 10 g of aprotinin/ml, and 10 g
of leupeptin/ml), and bound proteins were eluted in protein sample buffer and
analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), transferred
to filters, and used for Western blot analyses. Thirty micrograms of total protein
was used to confirm equal amounts of RhoA for each transfection condition. The
following antibodies were used for Western blot analyses to verify expression of
proteins: anti-HA (16B12; Covance), anti-RhoA (Transduction Labs), anti-Gq
(T. Kendall Harden, University of North Carolina), anti-G12 (Calbiochem),
and anti-G13 (Calbiochem).
Transient expression reporter gene assays. NIH 3T3 cells were transfected by
using Lipofectamine Plus. Three hours posttransfection, cells were placed in
starvation medium containing 0.5% bovine calf serum for 24 h. After starvation,
cells were rinsed once with ice-cold phosphate-buffered saline and then lysed in
300 l of 1
 luciferase cell lysis buffer (Becton Dickinson Co.) on ice for 10 min.
The analysis of cell lysates was performed by using enhanced chemiluminescent
reagents and a Monolight 2010 luminometer (Analytical Luminescence). The
(SREm)2-Luc reporter plasmid contains a luciferase gene whose expression is
under the control of an SRF-responsive promoter as described previously (42).
Thirty micrograms of total protein was resolved on a 4 to 20% gradient gel
(Bio-Rad), and Western blot analyses were performed to verify the expression of
transfected genes. All assays were performed at least in triplicate.
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RESULTS
RGS box of LARG associates with G subunits q, 12, and 13
in vivo. We first investigated the ability of the isolated RGS box
of LARG (Fig. 1) to associate with members of the G12, Gi,
and Gq family of G subunits. The isolated RGS box of p115
RhoGEF, which can associate with G12 and G13 but not
with Gq (24), was used as a control for these experiments. For
these analyses, we transiently overexpressed the isolated RGS
boxes of LARG or p115 RhoGEF (designated LARG-RGS
and p115-RGS, respectively) together with different G sub-
units. An anti-HA antibody was used to immunoprecipitate the
HA epitope-tagged LARG-RGS or p115-RGS from NIH 3T3
cells also coexpressing wt G12, G13, Gq, or Gi1. Both
G12 and G13 coimmunoprecipitated with LARG-RGS and
p115-RGS (Fig. 2). These interactions were observed only in
the presence of aluminum tetrafluoride (AlF4
	), a planar ion
that binds G to form a transition-state mimetic to which RGS
boxes have the highest affinity for G subunits (39, 44). Sur-
prisingly, we found that LARG-RGS, but not p115-RGS, also
interacted with Gq in an AlF4-dependent manner. We did
not observe any association of LARG-RGS or p115-RGS with
Gi1 (data not shown). Furthermore, G12, G13, or Gq did
not coprecipitate with an amino-terminal deletion mutant of
LARG (N754-LARG) that lacks the RGS domain, but a
LARG truncation mutant lacking solely the PDZ domain
(N308-LARG) (Fig. 1) did bind all three G subtypes in an
AlF4-dependent manner (data not shown). These results sug-
gest that LARG, unlike p115 RhoGEF, binds to Gq as well as
to G12 and G13, and this interaction is mediated through
the RGS box.
Our coimmunoprecipitation analyses suggest that the
LARG RGS box associates with Gq as well as G12 and
G13 in vivo. We therefore also examined the possibility that
expressing LARG-RGS could block Gq-, G12-, and G13-
mediated signaling. In addition to their capacity to promote
stress fiber formation and mediate focus formation in NIH 3T3
cells, activated mutants of G12, G13, and Gq also induce
transcriptional responses characteristic of RhoA (18), such as
FIG. 1. Functional domains and structural mutants of LARG. Schematic representations of full-length (FL), amino-terminal truncation
mutants (N308 and N754), and the isolated RGS box (LARG-box) proteins are shown. Numbers correspond to amino acids. HA, HA epitope
tag; PDZ, PSD-95/Discs-large/ZO-1 domain; NLS, putative nuclear localization signal; DH, DH domain; PH, PH domain.
FIG. 2. LARG RGS box complexes with activated G12, G13,
and Gq subunits in vivo. NIH 3T3 cells were cotransfected with
vectors that express HA epitope-tagged versions of the isolated RGS
box of p115 RhoGEF or LARG (1 g) and expression vectors encod-
ing wt G12, G13, or Gq (1 g). Whole-cell lysates were prepared
in the presence or absence of AlF4
	, which activates G subunits to
adopt a conformation mimicking the transition-state for GTP hydro-
lysis (44). HA-tagged RGS box proteins were immunoprecipitated (IP)
from whole cell lysates (800 g of total protein) with an anti-HA
(HA) monoclonal antibody and resolved by SDS-PAGE. Immuno-
precipitated p115-RGS and LARG-RGS protein and coimmunopre-
cipitated G12, G13, and Gq subunits were detected by immuno-
blot analyses (IB). To control for expression levels, separate aliquots of
each lysate (20 g) were taken before immunoprecipitation and re-
solved by SDS-PAGE and amounts of G12, G13, or Gq were
detected by immunoblot analyses.
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activation of SRF and concomitant expression from the c-fos
serum response element (7, 26). We performed transient trans-
fection assays to determine if LARG-RGS could impair the
ability of activated mutants of Gq, G12, and G13 to stim-
ulate an SRF-responsive luciferase reporter (Fig. 3). For these
analyses, we included an expression vector encoding RGS2, a
Gq-specific GAP (17). NIH 3T3 cells were transiently trans-
fected with expression vectors encoding GTPase-deficient
(Q3L), constitutively activated mutants of each G subunit,
either alone or together with expression plasmids for RGS2,
p115-RGS, or LARG-RGS, and an SRF-responsive reporter
gene plasmid (42). Expression of constitutively activated Gq,
G12, or G13 alone greatly enhanced SRF activity (five- to
sevenfold). As expected, the SRF activities induced by G12
and G13 were suppressed by coexpression with p115-RGS
but not RGS2. Conversely, Gq-induced SRF activation was
significantly decreased by RGS2 expression but not by p115
RhoGEF expression. These results are wholly consistent with
the known G specificities of these two RGS proteins (17, 24).
Consistent with our coprecipitation data, we found that coex-
pression of LARG-RGS caused an approximately 50% reduc-
tion in the ability of all three G subunits to stimulate SRF
activity. These observations, when taken together with the co-
precipitation analyses, support the ability of the LARG, but
not the p115 RhoGEF, RGS box to interact with Gq in vivo.
The LARG RGS box abolishes signaling and focus forma-
tion mediated by Gq- and G12-coupled GPCRs. We further
evaluated the ability of the LARG RGS box to modulate
Gq-mediated SRF activation by using a Gq-coupled mus-
carinic cholinergic receptor (m1-mAChR) system. Since the
natural agonist for m1-mAChR (acetylcholine) is not present
in serum, receptor activity can be induced by the addition of an
exogenous agonist such as carbachol to the growth medium.
NIH 3T3 cells stably expressing the m1-mAChR alone or to-
gether with either p115 RhoGEF or the LARG RGS box were
supertransfected with the SRF reporter plasmid and, where
indicated, RGS2. m1-mAChR-expressing NIH 3T3 cells in-
duced SRF activation in response to carbachol stimulation
(Fig. 4). Coexpression of LARG-RGS or RGS2 attenuated
SRF activation induced by carbachol (Fig. 4). In contrast,
coexpression of the p115-RGS had no effect on SRF acti-
vation elicited by the m1 muscarinic receptor. These find-
ings further suggest that the RGS box of LARG, unlike that
of p115 RhoGEF, is uniquely capable of modulating Gq-
as well as G12/13-mediated signal transduction events.
Our analyses above indicated that the RGS box of LARG,
but not that of p115 RhoGEF, interacts with and regulates the
function of Gq in vivo. To further assess this difference in G
specificity, we evaluated the ability of LARG-RGS and p115-
RGS to modulate the transforming activity of GPCRs that are
coupled to G13 or Gq. For these analyses, we determined if
coexpression of each RGS box could inhibit the ability of a
GPCR to cause focus formation in NIH 3T3 cells.
G2A was identified in a screen for novel oncogenes and is a
GPCR that causes G13-dependent activation of RhoA and
RhoA-dependent transformation of NIH 3T3 cells (20, 45). It
was previously shown that coexpression of the amino-terminal
RGS box of Lsc, the mouse ortholog of p115 RhoGEF, re-
sulted in complete reversion of G2A-expressing cells to a non-
transformed morphology (45). We therefore tested whether
the RGS box of LARG might also function to inhibit G13-
mediated signaling and transformation in G2A-transformed
NIH 3T3 cells. Expression of the isolated RGS box of LARG
or p115 RhoGEF greatly inhibited the transformation of NIH
3T3 cells induced by G2A overexpression (Fig. 5A). We also
found that expression of either RGS box completely abolished
the transforming activity of activated mutants of G12 and
G13 (data not shown) while neither blocked transformation
induced by activated Ras (Fig. 5A). These results suggest that
the LARG RGS box can specifically interdict signaling from
GPCR-mediated activation of G13.
Whereas G2A transformation involves the activation of
G13, Mas transformation appears to be mediated by Gi and
Gq activation (45, 46). When coexpressed with LARG-RGS,
the transforming activity of Mas was almost completely abol-
ished, whereas coexpression of p115-RGS had no effect (Fig.
5B). In our transformation assays, we found that expression of
activated Gq or activated Gi alone was unable to induce
focus formation in NIH 3T3 cells, and instead, coexpression of
both activated subunits was required to cause transformation
(I. E. Zohn and C. J. Der, unpublished observations). There-
fore, we were unable to determine if the LARG RGS box was
suppressing Gi-dependent transformation by performing co-
expression studies. However, since we have not detected Gi
association with LARG-RGS (data not shown), we suspect
that LARG-RGS inhibition of Mas transformation is mediated
by inhibition of Gq.
To further investigate the possibility that the LARG RGS
box can suppress Gq-induced transformation, we used a
Gq-coupled mAChR. Certain mAChR subtypes are known to
transform NIH 3T3 cells in a strictly agonist-dependent man-
ner (12). Thus, transforming activity is induced only in the
presence of exogenous carbachol. Gutkind and colleagues em-
FIG. 3. LARG RGS box attenuates G12-, G13-, and Gq-me-
diated SRF activation in NIH 3T3 cells. NIH 3T3 cells were transiently
cotransfected with expression plasmids (1 g) encoding LARG RGS,
p115 RGS, RGS2, and GTPase-deficient G12 (Q229L), G13
(Q226L), or Gq (Q229L) proteins and a luciferase reporter plasmid
(0.5 g) that is responsive to activation of SRF [(SREm)2-Luc]. After
transfection, cells were placed in 0.1% calf serum for 24 h. Cell lysates
were then analyzed for luciferase activity and normalized to cells trans-
fected with empty vectors (fold activation). All reporter assays were
performed in six-well plates in duplicate. Total cell lysates (30 g) were
analyzed for protein expression by Western blot analysis with anti-
G12, -G13, -Gq, or -HA antibodies (data not shown). The data
shown represent the averages of three experiments ( standard errors
of the means).
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ployed this approach to establish that Gq-coupled mAChRs
(m1, m3, and m5) are highly transforming, whereas Gi-coupled
mAChRs (m2 and m4) do not elicit focus-forming activity (12).
Therefore, we performed secondary focus formation transfor-
mation assays in NIH 3T3 cells stably expressing the Gq-
coupled m1-mAChR to evaluate the effect of the LARG RGS
box on Gq-mediated transforming activity. In the absence
of carbachol, cells stably transfected with m1-mAChR alone
or with m1-mAChR combined with the RGS box of p115
RhoGEF or LARG appeared morphologically indistinguish-
able from control (empty vector transfected) cells. However,
when maintained for 14 days in growth medium supplemented
with carbachol, the m1-mAChR-expressing cells and m1-
mAChR–p115 RhoGEF RGS box-cotransfected cells readily
formed foci in transformed cells (Fig. 5C). In contrast, carba-
chol-induced focus formation mediated by the m1 muscarinic
receptor was blocked by coexpression of LARG-RGS but not
p115-RGS. These results confirm the specificity of the LARG
RGS box for suppressing Gq-dependent transformation.
LARG enhances Gq-, G12-, and G13-mediated accumu-
lation of RhoA-GTP. Previous studies showed that activated
G13, but not G12 or Gq, stimulated the GEF activity of
p115 RhoGEF in vitro (15) and p115 RhoGEF activation of
SRF in vivo (27). Therefore, other Dbl family proteins must
mediate G12 and Gq activation of RhoA, and our present
analyses support such a role for LARG. Thus, we next inves-
tigated this possibility and evaluated the ability of G subunits
to cooperate with LARG to cause activation of RhoA in vivo.
For these analyses we generated expression vectors encoding
full-length LARG and two amino-terminally truncated ver-
sions (Fig. 1). The first truncation mutant, designated N308
LARG, lacks the amino-terminal sequences of LARG that are
deleted as a consequence of the formation of leukemia-asso-
ciated mixed-lineage leukemia-LARG fusion protein (i.e.,
lacking the PDZ domain but encoding the RGS box) (Fig. 1).
The second truncation mutant, designated N754 LARG, ad-
ditionally lacks the RGS box. Each LARG protein was ex-
pressed either alone or together with constitutively activated
mutants of Gq, G12, or G13 in NIH 3T3 cells, and RhoA
activation was assayed by affinity precipitation with GST-rho-
tekin RBD. Following precipitation, Western blot analyses
with a RhoA-specific antibody provided an assessment of the
formation of activated, GTP-bound RhoA, and blot analyses of
total cell lysates were done to verify the equivalent total RhoA
protein expression in each condition.
We found that the expression of each constitutively activated
G subunit alone, or of wt or truncated LARG protein alone,
caused a limited, but significant, increase in the amount of
activated GTP-bound RhoA (Fig. 6). Importantly, we found
that coexpression of activated Gq, G12, or G13 with full-
length or N308 LARG, but not N754 LARG, caused an
enhanced formation of GTP-bound RhoA. These data suggest
that Gq, G12, or G13 activation may result in enhanced
LARG DH domain catalytic activity in vivo and this coupling
of Gq, G12, or G13 to RhoA activation depends on the
presence of the RGS box but not the PDZ domain.
DISCUSSION
A wide variety of GPCRs have been shown to cause activa-
tion of RhoA (9, 34). Extracellular signal-mediated activa-
tion of Rho family GTPases typically involves activation of a
FIG. 4. LARG RGS box attenuates agonist-dependent m1-mAChR-mediated SRF activation in NIH 3T3 cells. NIH 3T3 cell lines stably
expressing the Gq-coupled m1-mAChR and the indicated RGS box proteins were transiently transfected with the (SREm)2-Luc SRF-responsive
reporter plasmid (0.5 g). NIH 3T3 cells stably expressing m1-mAChR alone were supertransfected with (SREm)2-Luc (0.5 g) and RGS2 (1 g).
After transfection, cells were placed in growth medium supplemented with 0.1% calf serum for 24 h. Cell lysates were than analyzed for luciferase
activity, and fold activation was determined by the number of relative luciferase units relative to the number of units seen with the empty vector
control. All reporter assays were performed in six-well plates in duplicate. The data shown are representative of at least three independent assays
performed on duplicate plates.
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FIG. 5. LARG RGS box abolishes focus formation mediated by Gq- and G13-coupled GPCRs. (A) LARG RGS box blocks G2A-mediated
transformation of NIH 3T3 cells. G2A is an oncogenic GPCR that couples to G13 (20). NIH 3T3 cells were cotransfected with expression vectors
encoding transforming oncoproteins G2A (0.5 g) or activated HRas(61L) (25 ng) along with vectors (1 g) that express the RGS box of p115
RhoGEF (p115-RGS) or LARG (LARG-RGS). Focus-forming activity was determined 14 days after transfection. The data shown represent the
average number of foci of three experiments performed in duplicate. (B) LARG RGS box blocks Mas-mediated transformation of NIH 3T3 cells.
Mas is an oncogenic GPCR that couples to Gq and Gi. NIH 3T3 cells were cotransfected with plasmid vectors encoding Mas (0.5 g) or
HRas(61L) (25 ng) either alone or together with vectors (1 g) encoding p115-RGS or LARG-RGS. Focus-forming activity was determined 14
days after transfection. The data shown represent the average number of foci of three experiments performed in duplicate. (C) LARG RGS box
blocks agonist-dependent m1-mAChR-mediated transformation of NIH 3T3 cells. Stable NIH 3T3 cell lines were established expressing the
Gq-coupled m1-mAChR and the indicated RGS box proteins. Cells were maintained in growth medium supplemented with either 100 M
carbachol (an m1-mAChR agonist) or vehicle, and focus-forming activity was determined after 12 days. The data shown represent the average
number of foci of three individual experiments performed in duplicate.
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Dbl family protein. p115 RhoGEF/Lsc and PDZ-RhoGEF/
GTRAP48, together with LARG, represent novel members of
the Dbl family that contain amino-terminal RGS boxes and are
RhoA-specific GEFs (8, 10, 11, 16, 31, 33). Since RGS boxes
can interact with specific G subunits, this group of Dbl family
proteins represents strong candidates for mediators of GPCR
activation of RhoA. p115 RhoGEF has been shown to enhance
the intrinsic GTPase activity of the G12/13 subfamily (24) and
to directly link G13, but not G12, to RhoA activation in
vitro (15) or to p115 RhoGEF signaling in vivo (27). However,
no RhoA GEF has yet been identified that directly links the
G subunits G12, Gq, or Gi with the activation of RhoA.
In the present study we evaluated the specificity of the LARG
RGS box towards G subunits that stimulate RhoA activation
in vivo. Unexpectedly, we found that the isolated RGS box of
LARG associates not only with G12 and G13, but also with
Gq in vivo and blocked the activity of G12- and Gq-cou-
pled GPCRs. Additionally, we determined that activated Gq,
as well as G12 and G13, synergistically enhanced LARG
stimulation of RhoA GTP formation in vivo. We suggest
LARG is functionally distinct from the other RGS box-con-
taining Dbl family proteins and can function as a critical me-
diator of RhoA activation by GPCRs that couple with Gq and
G12 as well as G13.
Our coimmunoprecipitation assays revealed that the LARG
RGS box associated with Gq as well as G12 and G13 in
vivo. This is in contrast to what has been described for the
previously studied RGS box-containing RhoA GEFs (p115
RhoGEF and PDZ-RhoGEF), which interact only with G12
and G13. Using the assay conditions with which we detected
LARG-RGS interaction with Gq, we verified that the RGS
box of p115 RhoGEF did not interact with Gq in vitro or in
vivo. During the course of our studies, Fukuhara et al. reported
that the LARG RGS box associated with GTPase-deficient
mutants of G12 (Q229L) and G13 (Q226L) but failed to
associate with the analogous mutant of Gq (Q229L) in vitro
(8). What is the basis for this apparent discrepancy in the
observations made in our study? Fukuhara et al. utilized mam-
malian cell-expressed constitutively activated (Q to L) G sub-
units in their binding analyses with LARG (8). In our initial
coprecipitation analyses with Q-to-L mutants of G proteins,
we also observed no interaction between the LARG RGS box
and constitutively activated Gq but we also failed to find
association with G12 or G13 (data not shown). However,
previous studies indicated that RGS proteins bind with highest
affinity to G subunits in the transition state for GTP hydro-
lysis (2, 39). When cells are lysed in the presence of aluminum
tetrafluoride, the conformation of GDP-bound, AlF4
	-acti-
vated G subunit mimics the transition state of GTP hydroly-
FIG. 6. Coexpression of activated G12, G13, and Gq enhances
LARG-mediated RhoA activation. NIH 3T3 cells were transiently
transfected with expression plasmids (1 g) encoding activated
mutants of G12 (A), G13 (B), Gq (C); full-length (2 g), N308,
or N754 LARG; or the indicated combinations of activated G
subunits and LARG. After transfection, cells were cultured for 24 h in
growth medium supplemented with low serum (0.1%) and lysed, and
the lysates (800 g total protein) were used in GST pull-down assays
using GST-rhotekin RBD immobilized on glutathione-agarose beads
(20 g). Bound proteins and total cell lysates were analyzed by West-
ern blot analyses with anti-RhoA antibodies. The expression of G
subunits and LARG was analyzed by Western blot analyses of total cell
lysates using antibodies to G12, G13, Gq, or HA (data not shown).
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sis. Only in the presence of AlF4
	 did we observe an interac-
tion between the LARG RGS box and Gq, G12, and G13.
Hart et al. and Wells et al. also observed an AlF4
	-dependent
association between G13 and p115 RhoGEF (15, 41). Fur-
thermore, in their initial characterization of PDZ-Rho-GEF,
Fukuhara et al. (10) also performed coprecipitation analyses
utilizing the Q-to-L mutants of G12 and G13 in the pres-
ence of aluminum fluoride in the lysis buffer. Thus, we do not
believe that our observed interaction between the LARG RGS
box and Gq is an artifact of our coimmunoprecipitation con-
ditions since, in this same assay, the RGS box of p115 RhoGEF
did not associate with Gq and neither the p115 RhoGEF nor
the LARG RGS box was seen to bind Gi1. Finally, LARG-
RGS, but not p115-RGS, blocked Gq-stimulated activation of
SRF. Thus, in contrast to the RGS box of p115 RhoGEF, the
RGS box of LARG can interact with Gq. A demonstration
that endogenous LARG can form a stable complex with en-
dogenously activated G subunits would be one approach to
verify the physiological significance of our observations. How-
ever, in light of the low affinity of RGS boxes for G subunits,
we are not aware that any endogenous RGS box-containing
protein has been shown to complex with activated G subunits.
Instead, we are currently determining whether the LARG
RGS box exhibits higher affinity for Gq, G12, or G13 and
GAP activity for Gq. These analyses may provide some indi-
cation regarding how LARG may regulate the specificity of
signaling from GPCRs that are coupled to different G sub-
units.
Further support for the ability of the LARG RGS box to
interact with G13 and Gq comes from our demonstration
that the isolated RGS box of LARG blocked the transforming
activity of GPCRs that are coupled to these G subunits. G2A
causes p115 RhoGEF/Lsc- and RhoA-dependent transforma-
tion (45). G2A also efficiently induces stress fiber formation in
mouse fibroblasts lacking G12 or Gq, but not G13, indi-
cating that G13 is the key mediator of G2A activation of
RhoA (20). Although a recent report suggested that this re-
ceptor can couple to Gi (21), pertussis toxin failed to inhibit
the ability of G2A to induce NIH 3T3 cell transformation,
indicating that G2A is not mediating transformation through
Gi/o subunits (20, 45). This exclusion of G12 and Gq as
candidate mediators of G2A signaling, coupled with our find-
ing that LARG fails to associate with Gi after AlF4 treat-
ment, suggests that inhibition of G2A transforming activity by
the LARG RGS box most likely occurs via interdiction of
signal transduction from G13 to RhoA.
Our additional finding that the RGS box of LARG, but not
p115 RhoGEF, inhibited m1 muscarinic receptor signaling and
transformation, a strictly Gq-linked receptor and activator of
RhoA (7), suggests that the LARG RGS box specifically in-
teracts with Gq. Similarly, the ability of the RGS box of
LARG to suppress the transforming activity of Mas, a GPCR
that is coupled to Gi and Gq, is also likely to be due to
inhibition of activated Gq-mediated signaling pathways.
While these cellular assays suggest that the LARG RGS box
has GAP activity toward Gq, G12, and G13, we are
currently evaluating this possibility more directly with puri-
fied recombinant G and LARG proteins in single-turnover
GTPase assays. Interestingly, the RGS box of the closely re-
lated GTRAP48 was recently found to possess only poor GAP
activity towards G12/13 proteins relative to p115 RhoGEF
(41).
Various indirect analyses suggest that chronically activated
mutants G12, G13, and Gq may activate RhoA (4, 26, 45).
Our data showing that activated versions of these G subunits
cause an increase in RhoA GTP verify this possibility. While
p115 RhoGEF has been shown to connect G13 activation
with RhoA-specific exchange activity (15), the link that medi-
ates RhoA activation by G12 and Gq has not been deter-
mined. Although the ability of LARG to activate RhoA by
coexpressing activated forms of G12 or G13 could not be
augmented in previous preliminary observations (31), the
present study showed that LARG can mediate G12 and Gq,
as well as G13, activation of RhoA. The different observa-
tions made in the present study are most likely due to different
cell types used in the analyses (NIH 3T3 versus 293T) as well
as differences in the protocols used for transfection and cell
lysis. Using the same cell type in which our transformation
assays were done, namely NIH 3T3 cells, we determined that
coexpression of constitutively activated versions of all three G
subunits synergistically enhanced (two- to threefold above ad-
ditive) the ability of LARG to promote the formation of active,
GTP-bound RhoA in vivo and this cooperative activity was
seen only with full-length or a truncation variant of LARG that
contained the RGS box. We are further evaluating the ability
of LARG to link Gq to RhoA activation by using purified
recombinant G subunits, LARG, and RhoA in in vitro ex-
change assays. Recent analyses determined that G13 binding
to p115 RhoGEF involves sequences outside the RGS box and
may involve the DH and PH domains (41). Our G binding
studies utilized a fragment of LARG corresponding to the
RGS box alone, suggesting that the RGS box alone is sufficient
for G interaction but leaving unanswered whether additional
G contacts with other LARG domain(s) are required for G
specificity or G-mediated GEF activation. However, prelim-
inary studies suggest that the PDZ domain does not decouple
the LARG protein’s ability to mediate signaling events through
activated G subunits. We are currently perusing structure-
function studies to determine if other signaling domains pres-
ent in LARG mediate interactions with specific G subunits.
In summary, our observations show that, unlike other RGS
box RhoGEF family members, LARG associates with and neg-
atively regulates Gq in addition to the G12 subfamily of G
subunits. Our studies further suggest that the binding of acti-
vated GTP-bound Gq, as well as G12 and G13, to the RGS
box of LARG enhances RhoA activation in cells. LARG tran-
scripts are expressed ubiquitously. Hence, we suggest that
LARG may serve as a mediator of RhoA activation by GPCRs
that are coupled to Gq as well as G12 and G13 in a wide
variety of cells.
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